These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


199 related items for PubMed ID: 20336261

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Structures and thermodynamics of Alzheimer's amyloid-beta Abeta(16-35) monomer and dimer by replica exchange molecular dynamics simulations: implication for full-length Abeta fibrillation.
    Chebaro Y, Mousseau N, Derreumaux P.
    J Phys Chem B; 2009 May 28; 113(21):7668-75. PubMed ID: 19415895
    [Abstract] [Full Text] [Related]

  • 5. Energy landscapes of the monomer and dimer of the Alzheimer's peptide Abeta(1-28).
    Dong X, Chen W, Mousseau N, Derreumaux P.
    J Chem Phys; 2008 Mar 28; 128(12):125108. PubMed ID: 18376983
    [Abstract] [Full Text] [Related]

  • 6. Computational study on the structural diversity of amyloid Beta Peptide (abeta(10-35)) oligomers.
    Jang S, Shin S.
    J Phys Chem B; 2008 Mar 20; 112(11):3479-84. PubMed ID: 18303879
    [Abstract] [Full Text] [Related]

  • 7. Antiparallel beta-sheet: a signature structure of the oligomeric amyloid beta-peptide.
    Cerf E, Sarroukh R, Tamamizu-Kato S, Breydo L, Derclaye S, Dufrêne YF, Narayanaswami V, Goormaghtigh E, Ruysschaert JM, Raussens V.
    Biochem J; 2009 Jul 15; 421(3):415-23. PubMed ID: 19435461
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Following the aggregation of amyloid-forming peptides by computer simulations.
    Melquiond A, Boucher G, Mousseau N, Derreumaux P.
    J Chem Phys; 2005 May 01; 122(17):174904. PubMed ID: 15910066
    [Abstract] [Full Text] [Related]

  • 12. Multiple quantum solid-state NMR indicates a parallel, not antiparallel, organization of beta-sheets in Alzheimer's beta-amyloid fibrils.
    Antzutkin ON, Balbach JJ, Leapman RD, Rizzo NW, Reed J, Tycko R.
    Proc Natl Acad Sci U S A; 2000 Nov 21; 97(24):13045-50. PubMed ID: 11069287
    [Abstract] [Full Text] [Related]

  • 13. Folding landscapes of the Alzheimer amyloid-beta(12-28) peptide.
    Baumketner A, Shea JE.
    J Mol Biol; 2006 Sep 22; 362(3):567-79. PubMed ID: 16930617
    [Abstract] [Full Text] [Related]

  • 14. Conversion of non-fibrillar beta-sheet oligomers into amyloid fibrils in Alzheimer's disease amyloid peptide aggregation.
    Benseny-Cases N, Cócera M, Cladera J.
    Biochem Biophys Res Commun; 2007 Oct 05; 361(4):916-21. PubMed ID: 17679138
    [Abstract] [Full Text] [Related]

  • 15. Influence of the solvent on the self-assembly of a modified amyloid beta peptide fragment. II. NMR and computer simulation investigation.
    Hamley IW, Nutt DR, Brown GD, Miravet JF, Escuder B, Rodríguez-Llansola F.
    J Phys Chem B; 2010 Jan 21; 114(2):940-51. PubMed ID: 20039666
    [Abstract] [Full Text] [Related]

  • 16. Structural studies of soluble oligomers of the Alzheimer beta-amyloid peptide.
    Huang TH, Yang DS, Plaskos NP, Go S, Yip CM, Fraser PE, Chakrabartty A.
    J Mol Biol; 2000 Mar 17; 297(1):73-87. PubMed ID: 10704308
    [Abstract] [Full Text] [Related]

  • 17. Mechanism of copper(II) inhibiting Alzheimer's amyloid beta-peptide from aggregation: a molecular dynamics investigation.
    Jiao Y, Yang P.
    J Phys Chem B; 2007 Jul 05; 111(26):7646-55. PubMed ID: 17564430
    [Abstract] [Full Text] [Related]

  • 18. Structural variations in the cross-beta core of amyloid beta fibrils revealed by deep UV resonance Raman spectroscopy.
    Popova LA, Kodali R, Wetzel R, Lednev IK.
    J Am Chem Soc; 2010 May 12; 132(18):6324-8. PubMed ID: 20405832
    [Abstract] [Full Text] [Related]

  • 19. Development of a proteolytically stable retro-inverso peptide inhibitor of beta-amyloid oligomerization as a potential novel treatment for Alzheimer's disease.
    Taylor M, Moore S, Mayes J, Parkin E, Beeg M, Canovi M, Gobbi M, Mann DM, Allsop D.
    Biochemistry; 2010 Apr 20; 49(15):3261-72. PubMed ID: 20230062
    [Abstract] [Full Text] [Related]

  • 20. Effects of G33A and G33I mutations on the structures of monomer and dimer of the amyloid-β fragment 29-42 by replica exchange molecular dynamics simulations.
    Lu Y, Wei G, Derreumaux P.
    J Phys Chem B; 2011 Feb 10; 115(5):1282-8. PubMed ID: 21186801
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.